The purpose of our study is to use lipoprotein particle parameters detected by NMR spectroscopy to cross-sectionally analyze the relationship between expression of APOE alleles, lipoprotein particles, and disease severity in CHD patients being treated with statins, so as to provide additional evidence for the efficacy of cholesterol-lowering therapy. This evidence concerns the gene APOE and coronary artery disorder.